News for hackers. Stuff that matters.

A comment on Third member of U.S. FDA advisory panel resigns over Alzheimer’s drug approval. Parent comment

Re:Third member of U.S. FDA advisory panel resigns over Alzh... by kvathupo on Friday June 11, 2021 @10:11AM (#27473589)
Frankly, I think most doctors aren't qualified to make such a decision by virtue of lacking PhDs: their expertise is in clinical care, not in evaluating research.
[ Parent | on HN ]

There are no comments on this comment yet.